In conclusion, we showed that CRC featured systemic inflammation, changes in the serum concentrations of eotaxin-1 and IL-8, and correlated changes in gene expression in peripheral blood CD4+ cells. The gene discussed is CCL11; the disease is colorectal carcinoma.